Investor mix
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 25% |
| Other / undisclosed | 6 | 75% |
Preclinical biopharma developing RAS targeting small molecule therapeutics
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 25% |
| Other / undisclosed | 6 | 75% |